A. Dusty Miller, B.A., B.S., Ph.D.
Affiliations: | 1984-2019 | Human Biology/Basic Sciences | Fred Hutchinson Cancer Research Center, Seattle, WA, United States |
| 1987-2019 | Pathology | University of Washington, Seattle, Seattle, WA |
Area:
Virology, Gene Therapy, Cell BiologyWebsite:
https://sharedresources.fredhutch.org/profile/miller-dustyGoogle:
"*A. Dusty Miller research*"Bio:
https://searchworks.stanford.edu/view/5604897
Cross-listing: Neurotree
Parents
Sign in to add mentor| James P. Whitlock, Jr. | grad student | 1979-1982 | Stanford (Neurotree) |
| Inder M. Verma | post-doc | 1982-1984 | Salk Institute (Cell & Gene Therapy Tree) |
Children
Sign in to add trainee| Theo D. Palmer | grad student | 1985-1992 | University of Washington (Neurotree) |
| Peter Kurre | grad student | 1997-1998 | Fred Hutchinson Cancer Center |
| Clarissa A. Dirks | grad student | 2001 | University of Washington (Neurotree) |
| Shan-Lu Liu | grad student | 2003 | University of Washington (Neurotree) |
| Neal S. Van Hoeven | grad student | 1999-2005 | University of Washington (Neurotree) |
| Michael J. Metzger | grad student | 2010 | University of Washington (Neurotree) |
| Andrew E. Vaughan | grad student | 2006-2011 | University of Washington (Neurotree) |
| David W. Russell | post-doc | Fred Hutchinson Cancer Center (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Štefánik M, Bhosale DS, Haviernik J, et al. (2022) Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses. Viruses. 14 |
| Chandrashekar A, Liu J, Martinot AJ, et al. (2020) SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science (New York, N.Y.) |
| Miller AD, De Las Heras M, Yu J, et al. (2017) Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer. Retrovirology. 14: 3 |
| Miller AD. (2014) Retroviral vectors: from cancer viruses to therapeutic tools. Human Gene Therapy. 25: 989-94 |
| Miller AD. (2014) Retroviral vector production. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. 80: Unit 12.5. |
| Wang Z, Halbert CL, Lee D, et al. (2014) Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model. Gene Therapy. 21: 363-70 |
| Mendoza R, Miller AD, Overbaugh J. (2013) Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A. Journal of Virology. 87: 2412-9 |
| Wang Z, Storb R, Halbert CL, et al. (2012) Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1501-7 |
| Mendoza R, Silverman RH, Klein EA, et al. (2012) No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients. Plos One. 7: e36073 |
| Vaughan AE, Mendoza R, Aranda R, et al. (2012) Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity. Journal of Virology. 86: 1661-9 |